MLNX Stock DD Mellanox Technologies, Ltd. 09/12/2014 14:21:00

New Post Public Reply Private Reply Replies (0) Message Board

Sep 12, 2014 at 3:20 PM

MLNX Mellanox Technologies, Ltd. $MLNX Company Overview

Stock Message Board Recent Posts http://investorshangout.com/search?q=MLNX&...mp;yt0=Go!

Last Updated: 09/12/2014 14:20:55

Current Price and Quotes
Last Price
Previous Close Open
Daily Range - 52wk Range -
Volume Dividend
Average Vol (30d) Yield

Financials
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 390,859 500,799 259,251 154,640
Cost of Revenue 135,239 157,936 92,015 40,550
Gross Profit 255,620 342,863 167,236 114,090
Operating Expenses

Research and Development 168,721 138,946 92,508 56,804
Sales, General and Admin. 107,236 85,609 62,135 33,848
Non-Recurring Items - - - -
Other - - - -
Operating Income (20,337) 118,308 12,593 23,438
Income From Continuing Operations

Add'l Income/Expense Items 1,228 1,259 759 (135)
Earnings Before Interest and Tax (19,109) 119,567 13,352 23,303
Interest Expense - - - -
Earnings Before Tax (19,109) 119,567 13,352 23,303
Income Tax 3,752 8,187 3,375 9,763
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (22,861) 111,380 9,977 13,540
Non Recurring Events

Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (22,861) 111,380 9,977 13,540
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (22,861) 111,380 9,977 13,540

Recent News

Sep 9, 2014 Semiconductors Stocks Technical Insight - Atmel, Texas Instruments, Mellanox Technologies, Broadcom, and International Rectifier
Sep 8, 2014 Mellanox End-to-End InfiniBand and Ethernet Interconnect Solutions Optimized for Intel(R) Xeon(R) E5-2600 v3 Product Family (code name "Haswell&quot

Platforms
Aug 25, 2014 Mellanox Enables Highly Efficient Virtual Desktop Infrastructure using VMware's Virtual SAN Storage Solution and Micron SSDs
Aug 25, 2014 New Zadara Storage Solution Using iSER RDMA Boosts Application Performance and Reduces Costs
Aug 5, 2014 Technical Data on Semiconductors Stocks -- Texas Instruments, Atmel, Mellanox Technologies, Silicon Laboratories, and Broadcom
Aug 4, 2014 Mellanox and ProLabs Collaborate to Shake up Data Centre Establishment
Jul 30, 2014 Mellanox Technologies, Ltd. to Present at Upcoming Investor Conferences
Jul 24, 2014 Mellanox Technologies, Ltd. Announces Second Quarter 2014 Financial Results
Jul 21, 2014 Mellanox Expands LinkX(TM) Family of Cables to Add Flexibility to Data Center Connectivity
Jul 17, 2014 Manufacturing Agreement, Schedule of Earnings Releases and Conference Calls, New Product, and Portfolio Expansion - Analyst Notes on Intel, TI, IDT, Mellanox and Vishay

1
2
3
next >

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

2026 Community Impact Week: Slam Dunk for Community Unity

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Pacira BioSciences Faces Shareholder Revolt in M&A Deal

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Duolingo Faces Lawsuit Over Alleged Investor Missteps

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

LEGO Mashes Star Wars and Marvel for Fans' Delight

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...